2011, nr. 1 - Academia de Ştiinţe a Moldovei

Ştiinţe Medicale
17 . Welch K.M.A. Stroke and migraine – the spectrum
of cause and eff ect. Funct Neurol., 2003; 18:121-126.
18. Moldovanu I., Dodick D.W., Odobescu S. Cefaleele,
durerile faciale și cervicale (diagnostic și tratament). Chișinau,
2007; 520 p.
19. Clasifi carea Internaţională a Tulburărilor Cefalalgice.
Ediţia a doua. Chișinău, 2004, 270 p.
20. Welch K.M.A. Relationship of stroke and migraine.
Neurology, 1994; 44(7):33-36.
21. Leao A.P.P. Spreading depression of activity in the
cerebral cortex. J. Neurophysiol., 1944; 7:359-390.
22.Rose K.M., Carson A.P., Sanford C.P. et al. Migraine
and other headaches: associations with Rose angina and coronary
heart disease. Neurology, 2004; 63:2233-2239.
23. Dreier J.P., Kleeberg J., Alam M., et al. Endothelin-
1-induced spreading depression in. rats is associated with
a microarea of selective neuronal necrosis. Exp. Biol. Med
(Maywood), 2007; 232:204-213.
24. Matijevic N., Wu K.K. Hypercoagulable states and
strokes. Curr. Atheroscler. Rep. 2006; 8:324-329.
25. Sarchielli P., Alberti A., Coppola F. et al. Plateletactivating
factor (PAF) in internal jugular venous blood of
migraine without aura patients assessed during migraine attacks.
Cephalalgia, 2004; 24:623-630.
26. Butler R., Morris A.D., Burchell B., Struthers A.D.
DD angiotensin- converting enzyme gene polymorphism is
associated with endo thelial dysfunction in normal humans.
Hypertension, 1999; 33:1164-1168.
27. Holmer S.R., Bickeboller H., Hengstenberg C. et
al. Angiotensin converting enzyme gene polymor phism and
myocardial infarction: a large association and linkage study.
Int. J. Biochem. Cell Biol, 2003; 35:955-962.
28. Zhang J.H., Kohara K., Yamamoto Y. et al. Genetic
predisposition to neurological symptoms in lacu nar infarction.
Cerebrovasc. Dis., 2004; 17:273-279.
29. Hassan A., Hunt B.J., O’Sullivan M. et al. Markers
of endothelial dysfunction in lacunar infarction and ischaemic
leukoaraiosis. Brain., 2003; 126:424-432.
30. Kowa H., Fusayasu E., Ijiri T. et al. Association of
the insertion/deletion polymorphism of the angio tensin Iconverting
enzyme gene in patients of migraine with aura.
Neurosci. Lett., 2005; 374:129-131.
31. Furchgott R.F., Zawadzki J.V. Th e obligatory role of
endothelial cells in the relaxation of arterial smooth muscle
by acetylcholine. Nature, 1980; 288: 373-376.
32. Moncada S., Palmer R.M., Higgs E.A. Th e discovery
of nitric oxide as the endogenous nitrovasodilator. Hypertension,
1988; 12(4):365-372.
33. Bonetti P.O., Lerman L.O., Lerman A. Endothelial
dysfunction: a marker of atherosclerotic risk. Arterioscler.
Th romb. Vase. Biol., 2003; 23:168-175.
34. Moskowitz M.A. Neurogenic infl ammation in the
pathophysiol ogy and treatment of migraine. Neurology,
1993; 43(Suppl. 3): S16-20.
35. Brandes J.L., Welch K.M., Salerno J., Brandes A.W.
C-Reactive pro tein increased in migraine. Headache, 2004;
44:489.
36. Haller H. Endothelial function. General considerations.
Drugs, 1997; 53 Suppl 1:1-10.
109
37. Faraci F.M., Heistad D.D. Regulation of the cerebral
circulation: role of endothelium and potassium channels.
Physiol. Rev., 1998; 78 (1):53-97.
38. Moncada S., Palmer R.M., Higgs E.A. Th e discovery
of nitric oxide as the endogenous nitrovasodilator. Hypertension,
1988; 12(4):365-372.
39. Luscher T.F. Endothelial control of vascular tone
and growth. Clin. Exp. Hipertens., [A] 1990;12(5):897-902.
40. Palmer R.M.J., Ashton D.S., Moncada S. Vascular
endothelial cells synthesize nitric oxide from L-arginine. Nature.,
1988; 333:664-666.
41. Kader K.N., Akella R., Ziats N.P. et.al. e-NOS-overexpressing
endothelial cells inhibit platelet aggregation and
smooth muscle cell proliferation in vitro. Tissue Eng. Jun;
6(3):241-251.
Rezumat
Rolul migrenei în apariţia afecţiunilor ischemice a
fost presupus încă la sfârșitul secolului XIX. O ipoteză a
riscului mai mare a afecţiunilor ischemice cerebrale și coronariene
la pacienţii migrenoși, însă, a fost formulată doar
la mijlocul anilor ’50 ai secolului trecut. La moment sunt
multiple dovezi, care demonstrează această ipoteză. Argumente
convingătoare că persoanele migrenoase prezintă un
risc sporit în dezvoltarea unui proces ischemic cerebral sau
coronarian acut, nu au fost, însă, deocamdată prezentate pe
deplin, cu toate că publicaţiile din ultimii ani au transformat,
de fapt, această ipoteză atractivă în argumente documentate,
cu un grad destul de înalt de certitudine.
Summary
Th e importance of migraine in the development of ischemic
disorders was suggested as far back at the end f XIX
century. But a hypothesis a higher risk of cerebral ischemic
and coronary diseases in migraineurs patients was formulated
only in the mid-fi ft ies of the past century. Currently
multiple proofs, confi rming this hypothesis, are off ered.
But convincing data about persons with a high risc of development
of an ischemic process have not been established.
Nevertheless, the recent year’s publications have actually
transformed this exiting hypothesis into documented arguments
with a high degree of certainty.
Резюме
Предположение о роли мигрени в возникновении
ишемических заболеваний, было сформулировано еще
в конце ХIХ века. Но гипотеза o более высоком риске
ишемических церебральных и коронарных расстройств
у больных мигренью былa сформулированa только в
середине 50-x годов прошлого столетия. В настоящее
время существует множество фактов, которые
подтверждают эту гипотезу. Тем не менее, многие
исследователи считают, что нет ещё убедительных
аргументов, которые доказывали бы повышенный риск
развития ишемических церебральных или коронарных
нарушений у указанных больных, несмотря на то, что
публикации последних лет трансформировали, на наш
взгляд, эту гипотезу в документированную систему
аргументации, с высокой степенью достоверности.